
Teva Pharmaceutical Industries Limited – OTC:TEVJF
Teva Pharmaceutical Industries Limited stock price today
Teva Pharmaceutical Industries Limited stock price monthly change
Teva Pharmaceutical Industries Limited stock price quarterly change
Teva Pharmaceutical Industries Limited stock price yearly change
Teva Pharmaceutical Industries Limited key metrics
Market Cap | 12.22B |
Enterprise value | 27.54B |
P/E | -3.73 |
EV/Sales | 1.84 |
EV/EBITDA | -28.62 |
Price/Sales | 0.58 |
Price/Book | 1.01 |
PEG ratio | N/A |
EPS | -0.40 |
Revenue | 16.01B |
EBITDA | 4.40B |
Income | -493M |
Revenue Q/Q | 4.67% |
Revenue Y/Y | 7.31% |
Profit margin | -15.77% |
Oper. margin | -14.06% |
Gross margin | 46.72% |
EBIT margin | -14.06% |
EBITDA margin | 27.49% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTeva Pharmaceutical Industries Limited stock price history
Teva Pharmaceutical Industries Limited stock forecast
Teva Pharmaceutical Industries Limited financial statements
Jun 2023 | 3.87B | -863M | -22.25% |
---|---|---|---|
Sep 2023 | 3.85B | 80M | 2.08% |
Dec 2023 | 4.45B | 429M | 9.63% |
Mar 2024 | 3.83B | -139M | -3.63% |
Mar 2024 | 3.83B | -139M | -3.63% |
---|---|---|---|
Sep 2025 | 4.06B | 766.50M | 18.84% |
Oct 2025 | 4.13B | 794.67M | 19.22% |
Dec 2025 | 4.23B | 894.26M | 21.13% |
Analysts Price target
Financials & Ratios estimates
2024-11-06 | 0.664 | -0.3857 |
---|
Payout ratio | 0% |
---|
2019 | 0.48% |
---|---|
2020 | |
2021 | |
2022 | |
2023 |
Jun 2023 | 43095000000 | 35.38B | 82.11% |
---|---|---|---|
Sep 2023 | 42088000000 | 34.57B | 82.15% |
Dec 2023 | 43479000000 | 35.35B | 81.31% |
Mar 2024 | 42773000000 | 35.23B | 82.37% |
Jun 2023 | 324M | 302M | -55M |
---|---|---|---|
Sep 2023 | 5M | 184M | -576M |
Dec 2023 | 1.18B | 301M | -576M |
Mar 2024 | 171M | -215M | -87M |
Teva Pharmaceutical Industries Limited alternative data
Aug 2023 | 34,004 |
---|---|
Sep 2023 | 34,004 |
Oct 2023 | 34,004 |
Nov 2023 | 34,004 |
Dec 2023 | 34,004 |
Jan 2024 | 34,004 |
Feb 2024 | 37,000 |
Mar 2024 | 35,001 |
Apr 2024 | 35,001 |
May 2024 | 35,001 |
Jun 2024 | 35,001 |
Jul 2024 | 35,001 |
Teva Pharmaceutical Industries Limited other data
Period | Buy | Sel |
---|---|---|
Feb 2022 | 0 | 87692 |
Mar 2022 | 0 | 170531 |
May 2022 | 0 | 130000 |
Jul 2022 | 0 | 58163 |
Aug 2022 | 0 | 55500 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | KALIF ELIYAHU SHARON officer: EVP, Chi.. | Restricted Share Units | 6,629 | N/A | N/A | ||
Option | KALIF ELIYAHU SHARON officer: EVP, Chi.. | Ordinary Shares | 6,629 | N/A | N/A | ||
Option | ZAKS TAL ZVI director | Restricted Share Units | 12,205 | N/A | N/A | ||
Option | ZAKS TAL ZVI director | Ordinary Shares | 12,205 | N/A | N/A | ||
Option | SCHULTZ KARE director, officer.. | Restricted Share Units | 116,389 | N/A | N/A | ||
Option | SCHULTZ KARE director, officer.. | Ordinary Shares | 116,389 | N/A | N/A | ||
Sale | KALIF ELIYAHU SHARON officer: EVP, Chi.. | Ordinary Shares | 55,500 | $10.07 | $558,719 | ||
Option | SHANI ELI officer: EVP,Global Marketing&P.. | Restricted Share Units | 1,581 | N/A | N/A | ||
Option | SHANI ELI officer: EVP,Global Marketing&P.. | Ordinary Shares | 1,581 | N/A | N/A | ||
Sale | STARK DAVID MATTHEW officer: Exec. VP Chief Legal O.. | Ordinary Shares | 58,163 | $9.04 | $525,619 |
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence
Why AstraZeneca May Be 2025's Most Underrated Pharma Stock
Why Investors Should Watch Teva Despite Regional Risks
Pfizer's Turnaround Story Is Stronger Than You Think
Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
Why Johnson & Johnson's Strong Buy Rating Is Justified (Rating Upgrade)
Top 4 Immunology Stocks Poised For Growth In 2025
Duvakitug And Teva's Growth: A Game Changer In Pharma
-
What's the price of Teva Pharmaceutical Industries Limited stock today?
One share of Teva Pharmaceutical Industries Limited stock can currently be purchased for approximately $14.32.
-
When is Teva Pharmaceutical Industries Limited's next earnings date?
Unfortunately, Teva Pharmaceutical Industries Limited's (TEVJF) next earnings date is currently unknown.
-
Does Teva Pharmaceutical Industries Limited pay dividends?
No, Teva Pharmaceutical Industries Limited does not pay dividends.
-
How much money does Teva Pharmaceutical Industries Limited make?
Teva Pharmaceutical Industries Limited has a market capitalization of 12.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.17% to 15.85B US dollars. Teva Pharmaceutical Industries Limited made a loss 559M US dollars in net income (profit) last year or -$0.39 on an earnings per share basis.
-
What is Teva Pharmaceutical Industries Limited's stock symbol?
Teva Pharmaceutical Industries Limited is traded on the OTC under the ticker symbol "TEVJF".
-
What is Teva Pharmaceutical Industries Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Teva Pharmaceutical Industries Limited?
Shares of Teva Pharmaceutical Industries Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Teva Pharmaceutical Industries Limited have?
As Jul 2024, Teva Pharmaceutical Industries Limited employs 35,001 workers.
-
When Teva Pharmaceutical Industries Limited went public?
Teva Pharmaceutical Industries Limited is publicly traded company for more then 15 years since IPO on 18 Jun 2010.
-
What is Teva Pharmaceutical Industries Limited's official website?
The official website for Teva Pharmaceutical Industries Limited is tevapharm.com.
-
How can i contact Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited can be reached via phone at +972 3 914 8213.
Teva Pharmaceutical Industries Limited company profile:

Teva Pharmaceutical Industries Limited
tevapharm.comOTC
34,004
Drug Manufacturers—Specialty & Generic
Healthcare
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Tel Aviv, 6944020
CIK: 0000818686
ISIN: IL0006290147
: